141 related articles for article (PubMed ID: 28572837)
1. Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer.
Fołtyn S; Strycharz-Dudziak M; Drop B; Boguszewska A; Polz-Dacewicz M
Infect Agent Cancer; 2017; 12():31. PubMed ID: 28572837
[TBL] [Abstract][Full Text] [Related]
2. Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection.
Strycharz-Dudziak M; Kiełczykowska M; Drop B; Świątek Ł; Kliszczewska E; Musik I; Polz-Dacewicz M
Oxid Med Cell Longev; 2019; 2019():5832410. PubMed ID: 31360295
[TBL] [Abstract][Full Text] [Related]
3. Transforming Growth Factor-β, Interleukin-10, and Serological Markers in EBV-associated Gastric Carcinoma.
Pachnia D; Drop B; Dworzańska A; Kliszczewska E; Polz-Dacewicz M
Anticancer Res; 2017 Sep; 37(9):4853-4858. PubMed ID: 28870905
[TBL] [Abstract][Full Text] [Related]
4. [Epstein-Barr virus antibodies in blood serum of patients with laryngeal cancer].
Morshed K; Polz-Dacewicz M; Szymański M; Ziaja M; Gołabek W
Otolaryngol Pol; 2002; 56(1):45-8. PubMed ID: 12053667
[TBL] [Abstract][Full Text] [Related]
5. Serum and Tissue Level of TLR9 in EBV-Associated Oropharyngeal Cancer.
Stępień E; Strycharz-Dudziak M; Malm M; Drop B; Polz-Dacewicz M
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439137
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas.
Szkaradkiewicz A; Kruk-Zagajewska A; Wal M; Jopek A; Wierzbicka M; Kuch A
Clin Exp Med; 2002 Nov; 2(3):137-41. PubMed ID: 12447611
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
9. Detection of Epstein-Barr viral DNA in serum using rapid-cycle PCR.
Mouritsen CL; Wittwer CT; Reed G; Khan TM; Martins TB; Jaskowski TD; Litwin CM; Hill HR
Biochem Mol Med; 1997 Apr; 60(2):161-8. PubMed ID: 9169098
[TBL] [Abstract][Full Text] [Related]
10. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer.
Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196
[TBL] [Abstract][Full Text] [Related]
12. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
[TBL] [Abstract][Full Text] [Related]
13. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
[TBL] [Abstract][Full Text] [Related]
15. Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer.
Drop B; Strycharz-Dudziak M; Kliszczewska E; Polz-Dacewicz M
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257122
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].
Luo YL; Chen H; Peng SG; Lin JH; Huang PY
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3516-9. PubMed ID: 24521892
[TBL] [Abstract][Full Text] [Related]
17. Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness.
Polz A; Morshed K; Drop B; Drop A; Polz-Dacewicz M
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254830
[TBL] [Abstract][Full Text] [Related]
18. Expression of Epstein-Barr virus antibodies EA-IgG, Rta-IgG, and VCA-IgA in nasopharyngeal carcinoma and their use in a combined diagnostic assay.
Li Y; Wang K; Yin SK; Zheng HL; Min DL
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050964
[TBL] [Abstract][Full Text] [Related]
19. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
20. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.
Luderer R; Kok M; Niesters HG; Schuurman R; de Weerdt O; Thijsen SF
Mol Diagn; 2005; 9(4):195-200. PubMed ID: 16392898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
